<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="28001">Vancomycin</z:chebi> is a <z:chebi fb="0" ids="24396">glycopeptide</z:chebi> antibiotic used in the prophylaxis and treatment of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> caused by <z:mp ids='MP_0001796'>Gram-positive</z:mp> resistant bacteria </plain></SENT>
<SENT sid="1" pm="."><plain>In recent years, several cases of <z:chebi fb="0" ids="28001">vancomycin</z:chebi>-associated <z:hpo ids='HP_0001973'>immune thrombocytopenia</z:hpo> have been presented as case reports, but the real incidence of this side effect is still unknown </plain></SENT>
<SENT sid="2" pm="."><plain>In this report, we would like to present a case during which we confronted with a great dilemma: urgent removal of whole defibrillator system due to highly suspected infective <z:hpo ids='HP_0100584'>endocarditis</z:hpo> or leaving the defibrillator in place and simply switching <z:chebi fb="0" ids="28001">vancomycin</z:chebi> to another antibiotic agent and wait </plain></SENT>
</text></document>